Clinical trial

Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for…

NCT00499967 · Gilead Sciences, Industry · Completed

Key facts

NCT number NCT00499967
Title Safety and Effectiveness Study of an Experimental Topical Ointment (GS-9191) for the Treatment of Genital Warts
Official title A Phase 1, Randomized, Double-Blind, Placebo-Controlled Assessment of the Safety, Tolerability, and Activity of GS-9191 Ointment for the Treatment of External Genital and Perianal Warts Caused by Human Papilloma Virus Infection
Lead sponsor Gilead Sciences, Industry
Status Completed
Phase Phase 1
Study type Interventional
Conditions Genital Warts
Intervention type Drug
Interventions GS-9191 ointment, GS-9191, Placebo
Enrollment 202
Start date Aug 1, 2007
Primary completion Feb 1, 2009
Completion Mar 1, 2009
First posted Jul 12, 2007
Last update posted Apr 9, 2009
Countries United States

At a glance

  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies